Drs Diana Isaacs and Natalie Bellini provide an overview of the types of insulin delivery systems used in type 1 diabetes (T1D) and type 2 diabetes (T2D), including injections, patches, and inhalable insulin.

Drs Diana Isaacs and Natalie Bellini discuss selecting the right insulin delivery method for patients with diabetes, and the challenges that arise with insulin injectables.

Expert health care practitioners review the different types of insulin formulations available for people with T1D or T2D, including regular and rapid-acting.

Drs Diana Isaacs and Natalie Bellini discuss the limitations of injectable insulins in achieving time-in-range and glucose targets in type 1 and type 2 diabetes.

Experts examine the use of Technosphere insulin, how it is delivered to the body, and the qualities of an ideal rapid-acting insulin analog in type 1 and type 2 diabetes.

Drs Diana Isaacs and Natalie Bellini share the FDA-approved patient populations for inhaled insulin use to manage diabetes, as well as who would not be a good candidate.

An expert endocrine clinical pharmacist and nurse practitioner discuss clinical trial data on how inhaled insulin affects glucose management in T1D and T2D.

Dr Diana Isaacs and Dr Natalie Bellini review adverse effects of inhaled insulin in patients with T1D and T2D.

Drs Diana Isaacs and Natalie Bellini compare dosing of inhaled insulin to injectable insulin for the management of diabetes.

Dr Diana Isaacs provides an overview of the latest developments in oral insulin to manage patients with diabetes.

Expert healthcare practitioners discuss ongoing studies of inhaled insulin in T2D and how it might fit into treatment protocol.

Drs Diana Isaacs and Natalie Bellini share takeaways for clinicians exploring non-invasive insulin delivery methods to manage diabetes.